Antibe Therapeutics Inc.

Antibe Therapeutics Inc. obtained protection under the Companies' Creditors Arrangement Act on April 9, 2024 in the Ontario Superior Court of Justice, under court file CV-24-717410-00CL. The list of creditors filed under s. 23(1)(a) of the CCAA, prepared from the company's books and records as at April 9, 2024 and covering claims greater than $1,000, runs to 66 rows and a stated total of $6,696,626 in Canadian dollars, with US-dollar amounts converted at 1.35. The largest claims are Lotus Clinical Research at $3,737,737, Patheon (Thermo Fisher) at $1,181,567 and Lonza Bend at $544,246; the list has no secured section, and fourteen rows, including aggregate entries for employees, directors and Canadian, US federal and US state tax authorities, carry a $1 placeholder for amounts then unknown. The proceedings are closed.